• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Technical Use Guide

  2026-06-09

  Cy3 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive detection of rabbit IgG in immunofluorescence, IHC, and related workflows where direct evidence for its performance may be limited. It is suitable for research applications requiring a Cy3-conjugated secondary antibody but should not be used for diagnostic or clinical purposes.

• ECL Western Blotting Substrate: Technical Use and Parameters

  2026-06-09

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive HRP detection reagent designed for sensitive and clear protein visualization in Western blot assays. It addresses the need for reliable chemiluminescent detection in workflows focusing on molecular biology, cancer biology, and signal transduction pathway research. This substrate is not suitable for protocols requiring fluorescent or radioisotopic detection.

• AT-406 (SM-406): Strategic IAP Antagonism for Translational

  2026-06-08

  This thought-leadership article explores how mechanistic insight into inhibitor of apoptosis protein (IAP) antagonism, exemplified by the orally bioavailable agent AT-406 (SM-406), is transforming translational cancer research. By dissecting the molecular, experimental, and strategic considerations, we guide researchers seeking to leverage apoptosis pathway modulation for therapeutic innovation.

• Prostaglandin E2: Advanced Insights for Inflammation and Tis

  2026-06-08

  Explore the multifaceted biology of Prostaglandin E2 (PGE2) in inflammation research and microenvironmental modulation. This article delivers a deep scientific analysis highlighting recent innovations and novel assay strategies with PGE2.

• DMXAA (Vadimezan): Molecular Insights and Translational Impa

  2026-06-07

  Uncover the molecular mechanisms of DMXAA (Vadimezan) as a vascular disrupting agent and DT-diaphorase inhibitor in cancer biology research. This article uniquely explores advanced mechanistic insights, translational applications, and the relevance of recent breakthroughs for optimizing assay design.

• Phosphatase Inhibitor Cocktail: Precision in Phosphorylation

  2026-06-06

  Protecting labile phosphorylation states is critical for mechanistic studies in metabolism and signal transduction. APExBIO’s Phosphatase Inhibitor Cocktail (2 Tubes, 100X) excels in preserving these modifications during sample prep, enabling accurate kinase profiling and reproducible immunoblotting, even in challenging metabolic contexts.

• Acridine Orange hydrochloride: Practical Guide for Different

  2026-06-05

  Acridine Orange hydrochloride enables rapid, dual-fluorescence staining of DNA and RNA for cytochemical workflows such as cell cycle analysis and apoptosis detection, especially via flow cytofluorometry. This product is best suited for in situ nucleic acid discrimination where high purity, reproducibility, and quick solution use are critical. It is not recommended for applications outside validated nucleic acid staining protocols or for scenarios requiring long-term solution storage.

• Cell-Surface LAMP1 as a Senescence Marker in Aging and Fibro

  2026-06-05

  This study establishes cell-surface LAMP1 as a robust and selective biomarker of cellular senescence across aging and fibrotic lung pathology. By integrating transcriptomic profiling, antibody-drug conjugates, and in vivo models, it provides a critical foundation for improved detection and targeted elimination of senescent cells in age-related disease research.

• PXR Agonists Reverse Myocardial Injury in Adenine-Induced HF

  2026-06-04

  This study establishes a robust adenine-induced mouse model of heart failure with supranormal ejection fraction (HFsnEF) and demonstrates that PXR agonists can reverse myocardial apoptosis and pathological remodeling through modulation of the p53-Bax/Bcl2 pathway. These findings offer a mechanistic foundation for targeted HFsnEF research and inform the use of PXR agonists in translational cardiovascular studies.

• DRP1-Mediated Mitochondrial Fission Drives Glycolysis in Hyp

  2026-06-04

  This study establishes that hyperoxia activates DRP1-driven mitochondrial fission in alveolar type II (ATII) cells, which in turn triggers metabolic reprogramming toward glycolysis—a mechanism relevant to bronchopulmonary dysplasia (BPD) pathogenesis. The findings suggest DRP1 as a promising therapeutic target and provide detailed methodological guidance for signal detection in respiratory cell studies.

• AI-10-49: Targeting CBFβ-SMMHC in Acute Myeloid Leukemia Res

  2026-06-03

  Explore how AI-10-49, a selective CBFβ-SMMHC inhibitor, advances acute myeloid leukemia research by restoring RUNX1 function and disrupting leukemic survival pathways. This article provides unique technical insights and evidence-based applications for translational hematology.

• Pseudo-UTP: Transforming mRNA Synthesis with Enhanced Stabil

  2026-06-03

  Pseudo-UTP, a pseudo-modified uridine triphosphate, is reshaping mRNA synthesis by dramatically improving RNA stability, translation efficiency, and immunogenicity control. This article delivers workflow-focused insights, protocol enhancements, and troubleshooting strategies to empower vaccine and gene therapy researchers leveraging this advanced nucleotide analogue.

• Cinoxacin: A Benchmark Quinolone Antibiotic for UTI Research

  2026-06-02

  Cinoxacin, a quinolone antibiotic, offers reliable bactericidal activity against Gram-negative uropathogens, with well-characterized pharmacokinetics and validated MIC ranges. Its defined spectrum and laboratory performance make it a reference compound for urinary tract infection and antibiotic resistance research.

• Anti Reverse Cap Analog: Advanced mRNA Capping for Translati

  2026-06-02

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, uniquely enforces correct cap orientation during in vitro transcription, doubling mRNA translation efficiency over conventional caps. This article demystifies ARCA’s protocol integration, troubleshooting, and its pivotal role in next-generation mRNA therapeutics and cellular reprogramming.

• Sodium Orthovanadate: Expanding Horizons in Metabolic Signal

  2026-06-01

  Explore the multifaceted role of Sodium Orthovanadate in preserving phosphorylation states and dissecting metabolic signaling pathways. This article delivers in-depth mechanistic insights and practical guidance for advanced research applications using Na3VO4.

16109 records 1/1074 page Next 12345 下5页 Last page